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Resistance to antifungal agents is a recurring and growing problem among patients with systemic fungal
infections. UV-induced Aspergillus nidulans mutants resistant to terbinafine have been identified, and we report
here the characterization of one such gene. A sib-selected, 6.6-kb genomic DNA fragment encodes a salicylate
1-monooxygenase (salA), and a fatty acid synthase subunit (fasC) confers terbinafine resistance upon trans-
formation of a sensitive strain. Subfragments carrying salA but not fasC confer terbinafine resistance. salA is
present as a single-copy gene on chromosome VI and encodes a protein of 473 amino acids that is homologous
to salicylate 1-monooxygenase, a well-characterized naphthalene-degrading enzyme in bacteria. salA transcript
accumulation analysis showed terbinafine-dependent induction in the wild type and the UV-induced mutant
Terb7, as well as overexpression in a strain containing the salA subgenomic DNA fragment, probably due to the
multicopy effect caused by the transformation event. Additional naphthalene degradation enzyme-coding genes
are present in fungal genomes, suggesting that resistance could follow degradation of the naphthalene ring
contained in terbinafine.
The incidence of fungal infections has increased in the last
20 years, primarily because of the increase in the number of
immunocompromised patients due to AIDS, malnutrition, the
indiscriminate use of antibiotics, chemotherapy, and artificial
immunosuppressive treatment in organ transplants (17). In
addition, the widespread use of antifungal agents has led to
clinical resistance. Thus, insights into molecular and genetic
mechanisms involved in resistance are needed to define treat-
ment strategies and to design new antifungal drugs.
Terbinafine is a generic antifungal agent used to treat superfi-
cial mycoses such as dermatophyte onychomycosis, dermato-
mycoses, tinea, and piedra (1, 6, 9, 20). Terbinafine interferes
with ergosterol biosynthesis by inhibiting a membrane-bound
squalene epoxidase (31). Inhibition of squalene epoxidase re-
sults in ergosterol deficiency with the accumulation of squalene,
which may be responsible for the observed “in vitro” fungicidal
activity (11, 26).
Besides the fact that fungi resistant to terbinafine have been
consistently isolated, little is known about the molecular mech-
anisms associated with resistance (14, 22, 30, 38). In one case,
a modified squalene epoxidase with reduced affinity for terbi-
nafine conferred terbinafine resistance to Nectria haemato-
cocca mutants (15) and, in another, a Candida albicans strain
was resistant to terbinafine due to activation of the multidrug
efflux transporter CDR2 (35). Also, a C. albicans mutant car-
rying CDR1 deletion resulted in azoles and terbinafine hyper-
susceptibility (36).
We report here the involvement of naphthalene degradation
as a possible mechanism of terbinafine resistance in Aspergillus
nidulans. Transformation experiments demonstrate that terbi-
nafine resistance is mediated through the overexpression of
salA, a gene that encodes a salicylate 1-monooxygenase. In
Pseudomonas putida, salicylate 1-monooxygenase catalyzes the
formation of catechol from salicylate, a required intermediate
of naphthalene degradation (2). Thus, terbinafine, which has a
naphthalene nucleus in its chemical structure, may be a sub-
strate for a salicylate-like part of an aromatic compound deg-
radation pathway in A. nidulans.
MATERIALS AND METHODS
Strains, media, and culture conditions. A. nidulans was cultivated at 37°C in
complete medium (CM) or minimal medium (MM) (27). The following strains
were used: the wild type, FGSCA26 (biA1 veA1), the terbinafine-resistant strains
Terb7 (pabaA1 tebA7 veA1) (30) and Terb7A (acrA1 tebA7 veA1), the transfor-
mation recipient strains GR5 (pyroA4 pyrG89 wA3 veA1) and RPA26 (biA1
argB::trpC801 trpC801 veA1). The mutant alleles were as follows: wA3, white
conidia; tebA7 and acrA1, terbinafine and acriflavin resistance, respectively, and
the auxotrophic markers; argB::trpC801, biA1, pabaA1, pyrG89, and pyroA4 for
arginine, biotin, p-aminobenzoic acid, uracil, and pyridoxine, respectively. Ter-
binafine [(E)-N-(6,6-dimethyl-2-hepten-4-yn-yl)-N-methyl-1-naphthalene meth-
anamine] was from Sandoz AG, dissolved in dimethyl sulfoxide, and added to
solid or liquid medium. An agar dilution assay was used for terbinafine suscep-
tibility testing. A 100-l suspension of the conidia of each strain (107 conidia per
ml) was inoculated into solid-CM dishes with various concentrations of terbin-
afine, followed by incubation at 37°C for 3 days. The MIC corresponds to the
lowest concentration of the drug at which there is no macroscopic growth. All
assays were carried out in triplicate (8). Escherichia coli strain DH5 (12) or
XL1-Blue (Stratagene) was used for the propagation of plasmid DNA, which was
cultivated at 37°C in Luria-Bertani broth amended with 50 g of ampicillin/ml.
Molecular nucleic acid manipulation techniques and sequencing. DNA ma-
nipulation and cloning procedures were performed as described either by Sam-
brook et al. (33) or by the supplier of enzymes and nucleic acid reagents. Shotgun
subcloning, random clone sampling (Fig. 1C), and nucleotide sequence were
determined by the dideoxynucleotide chain termination method (34) using Big-
Dye terminator cycle sequencing (Perkin-Elmer) in an ABI Prism 377 DNA
sequencer. DNA sequence data files were assembled by using the Phred, Phrap,
and Consed packages (7, 10).
The original terbinafine-resistant plasmid was subcloned into smaller frag-
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ments by cleaving pD02 fragment with XbaI and PstI, resulting in 3.3-kb XbaI-
PstI and 3.1-kb XbaI fragments. Further subcloning, isolating the fasC and salA
open reading frames (ORFs), was pursued by PCR amplification (21) of the
indicated regions on plasmid pD02/36 (shown in Fig. 1) with specific primers (see
below). PCR product were cloned and propagated in E. coli with the pGEM-T
Easy vector (Promega).
The following oligonucleotides were used: pUCM13 forward, 5-GTAAAAC
GACGGCCAGT-3; pUCM13 reverse, 5-CAGGAAACAGCTATGAC-3; P1
(fas1-5), 5-GTGTTTTAGCATTCTCGCC-3; P2 (Anfatty16), 5-AGGATCAC
GACATTCACTTG-3; P3 (ansalA4), 5-CTCCAAGTCGCCCCCAATC-3 and
P4 (sal1-5), 5-CACGGGACGGGAACACCATC-3
Library construction. Total DNA from the Terb7A was extracted by the
method of Reader and Broda (29) from a 12-h-old liquid culture shaken at 37°C
after the inoculation of 107 conidia per ml. Partially Sau3AI-digested DNA
fragments were ligated to the pRG4 shuttle vector (19), which confers uracil
auxotropy when integrated into the genome of A. nidulans strain GR5, and
transformed into E. coli XL1-Blue by electroporation. A total of 17,856 clones
with an average insert size of 6.5 kb were recovered, and 7,680 of them were
transformed into strain GR5 (1.6-fold genome coverage).
Transformation and sib selection. Transformation experiments were per-
formed as previously described (40), except that the protoplasts were made with
Glucanex (Novo Nordisk) rather than with Novozym. A sib selection screen with
modifications (33) was used in order to rescue a recombinant plasmid bearing the
gene that confers terbinafine resistance. The approach is based on the concept of
dividing a large genomic library into a manageable number of pools, each
consisting of 960 clones (10 96-well plates). These pools are then tested for the
ability to confer terbinafine resistance in 1 g of terbinafine/ml. After a pool is
identified, it is subdivided into successively smaller and smaller pools, until a
unique recombinant plasmid is isolated. Once an individual plasmid was identi-
fied, the cloned insert was sequenced and characterized.
Southern and Northern blot hybridizations. Southern blot analysis was per-
formed by standard techniques (33). For Northern blots, total RNA isolation of
1 to 2 g of lyophilized ground mycelium was obtained by using the TRIzol
method (4) and isolated according to manufacturer recommendations (Gibco-
BRL). Northern blot analysis was performed as described elsewhere (42). Briefly,
10 g of total RNA was separated on 1.1% agarose containing 3% formaldehyde
and blotted onto nylon membranes (Hybond N; Amersham Pharmacia Bio-
tech). [32P]CTP-labeled probes were used to hybridize the membrane with mod-
ified Church buffer (5, 42) at 65°C for 16 to 20 h. Blots were washed and exposed
to film and developed according to the method of Sambrook et al. (33).
The GenBank accession numbers for salA and fasC are AF316427 and
AY120937, respectively.
RESULTS
Isolation of a gene that alters A. nidulans susceptibility to
terbinafine. To better understand terbinafine resistance, we
screened for recombinant plasmids able to turn sensitive
FIG. 1. The salA gene confers terbinafine resistance in A. nidulans. (A) Identification of a subgenomic DNA fragment (pD02) that confers
terbinafine resistance. Strain GR5 was transformed with plasmid pD02, which was shown in a sib selection experiment to induce terbinafine
resistance. Colonies are independent transformants randomly selected after transformation with pD02 and grown on medium with or without 1
g of terbinafine/ml. (B) Southern blot analysis of the genomic DNA of A. nidulans. Genomic DNA from GR5 (lanes P) and two pD02
transformant strains (lanes T1 and T2) were digested with EcoRI or XbaI, size fractionated through a 1.0% agarose gel, and blotted as described
in Materials and Methods. The probe used was the salA fragment obtained from pD02/36/sal contained in pGEM-T Easy vector. Size markers (in
kilobases) are indicated at right of the blot. (C) Salicylate 1-monooxygenase confers terbinafine resistance. Plasmid pD02 was subcloned, and the
genomic DNA sequence of the region was determined. Two ORFs, fasC and salA, were identified. DNA-mediated transformation-dependent
resistance analyses showed that only fragments that contain salA are terbinafine resistant. Primers P1 to P4 were used to construct the subclones
pD02/36/sal and pD02/36/fas.
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strains resistant that were made from genomic DNA of strain
TerbA7, whose resistance to terbinafine had been genetically
defined previously (30). We isolated a recombinant plasmid,
pD02, which was able to change GR5 strain from being sensi-
tive to being resistant to terbinafine. To confirm that the com-
plementing activity did not arise from spontaneous reversions,
the plasmid was retransformed into GR5.
Figure 1A shows that transformation of plasmid pD02 into
GR5 results in multiple-level terbinafine-resistant strains. Fig-
ure 1C shows the subcloning, a physical map of the 6.6-kb
chromosomal region contained in pD02, and mapping of the
terbinafine resistance to a single ORF. The genomic DNA
sequence reveals two ORFs: fasC, encoding the beta subunit of
the A. nidulans fatty acid synthase (3), and salA, a salicylate
1-monooxygenase-like protein known to be associated with
naphthalene degradation in Pseudomonas stutzeri AN10 (2).
The subclones pD02/36 and pD02/30 were transformed into A.
nidulans, and only pD02/36 was able to confer terbinafine
resistance (Fig. 1C). Two additional genomic subregions were
created by using PCR-amplified fragments and maintained in
pGEM-T. Only the salA-containing fragment was capable to
confer terbinafine resistance (Fig. 1C).
Genomic characterization and deletion of the salA locus.
The salA ORF is contained by 1,521 bp encoding a 473-amino-
acid residue protein (GenBank accession number AF316427)
interrupted by one putative intron (positions 578 and 680)
deduced from consensus sequence of fungi. The predicted
peptide encodes a salicylate 1-monooxygenase, an enzyme in-
volved in naphthalene degradation. Table 1 shows that all fully
sequenced fungal genomes to date contain at least one pre-
dicted protein product with high degree of homology to A.
nidulans salA.
Restriction enzyme Southern genomic mapping indicates
that salA is present as a single copy in the genome (Fig. 1B,
lanes P). Hybridization of a radioactively labeled salA DNA
fragment with blotted pulsed-field electrophoresis separated
chromosomes (data not shown) and the minimal tiling cosmid
collection (28) identify a single cosmid (data not shown), sug-
gesting that salA is physically located on chromosome VI. The
profile of Southern blot hybridization was consistent with salA
being a single-copy gene suitable for targeted gene disruption
experiments. The inactivation of gene salA in strain RPA26
did not change the sensitivity of the fungus to terbinafine,
i.e., the relative terbinafine resistance of wild-type, RPA26,
FIG. 2. Terbinafine-dependent and overexpressed salA transcript accumulation in wild-type and mutant strains. salA transcript accumulation
analysis in response to various concentrations of terbinafine in wild type, Terb7, and a pD02 transformant was carried out.
TABLE 1. Salicylate monooxygenase salA genes in filamentous fungi
Analysis type and
ORF or locus Organism
BLASTp or TBLASTn analysisa
P Bit score
Identities Positives No. of
gaps (%)aa or bp % aa or bp %
BLASTp
AN3382.1 Aspergillus nidulans 1E00 878 435/473 91 435/473 91 0
MG10012.3 Magnaporthe grisea 1E70 263 159/439 36 245/439 55 6
NCU07598.1 Neurospora crassa 1E54 209 136/438 31 214/438 48 12
FG03657.1 Fusarium graminearum 2E52 202 131/407 32 206/407 50 9
nahG Pseudomonas putida 2E27 122 114/441 25 197/441 44 17
TBLASTn
1.190 (sfd 16) Ustilago maydis 2E25 113 118/437 27 183/437 41 4
1.143 (sfd 7) Coprinus cinereus 3E08 57 57/218 26 89/218 40 20
a BLASTp, the A. nidulans salA amino acid sequence was compared with the predicted ORFs of fully sequenced genomes; TBLASTn, the A. nidulans salA amino
acid sequence was compared with the translated genomic nucleotide sequence. BLASTp identities are expressed as amino acids (aa); TBLASTn identities are expressed
as base pairs. Identity is the extent to which two amino acid sequences are invariant, expressed as the number identical amino acids/total amino acids in the protein.
Positive is the extent to which protein sequences are related, expressed as the number of similar amino acids/total amino acids in the protein.
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and salA mutant strains, expressed as the terbinafine MIC,
was 0.2 g/ml.
Terbinafine-dependent salA transcript accumulation. The
mutation in Terb7, which confers semidominant terbinafine
resistance, has been mapped to chromosome IV (30). Thus,
the pD02 DNA insert, which maps to chromosome VI and
encodes SalA, mediates terbinafine resistance, apparently in-
dependently of the tebA7 mutation.
Figure 2 shows terbinafine-dependent, salA transcript accu-
mulation in a wild-type strain, a pD02-transformant and Terb7
(Fig. 1A and C). Vegetative mycelia were incubated in liquid
shake-flask cultures with the indicated amounts of terbinafine
and total RNA extracted, separated by gel electrophoresis,
blotted onto nylon membranes, and hybridized with a radio-
actively labeled salA probe.
The presence of terbinafine promotes accumulation salA
transcript, which appears to be a transcriptionally regulated
event in the wild-type (sensitive) and Terb7 (resistant) strains
but not in a pD02 transformant (resistant). Figure 2 shows that
the salA transcript accumulates when terbinafine was added to
the culture medium at 2 and 20 g/ml in a wild-type strain and
Terb7; however, the expression of salA is terbinafine indepen-
dent in a pD02 transformant at the concentrations assayed (2
to 40 g/ml). Interestingly, salA transcript does not accumulate
when terbinafine is 40 g/ml, except for the pD02 transformant
(terbinafine independent) (Fig. 2).
Other fungal genes associated with naphthalene degrada-
tion in filamentous fungi. One possible explanation for the
observations described in Fig. 2 relies on the notion that the
mutation in strain Terb7 targets a regulatory gene located on
chromosome IV, which affects the expression of salA, located
on chromosome VI. In pD02 transformants overexpression of
the salicylate 1-monooxygenase transcript causes terbinafine
resistance and is apparently independent of tebA7. Terbinafine
contains a naphthalene ring, a possible substrate for the A.
nidulans SalA. Naphthalene degradation as is typically ob-
served in bacteria involves a series of enzymes and has not yet
been described in fungi.
Table 2 gives the homology scores of the closest fungal
homolog to microorganism genes involved in naphthalene deg-
radation. Genes that are present in A. nidulans and other
filamentous fungi are as follows: 2-hydroxychromene-2-carbox-
ylate isomerase, P  4e40 in A. nidulans only; salicylaldehyde
dehydrogenase; P  6e92, 1e91, 2e96, and 8e94; salicylate
1-monooxygenase, P  2e63, 1e32, 6e42, and 8e53; and
2-hydroxymuconic semialdehyde dehydrogenase, P  9e94,
4e98, 2e91, and 3e90 in A. nidulans, Magnaporthe grisea,
Neurospora crassa, and Fusarium graminearum, respectively.
Genes that could not be found through homology matching
fungal genome database entries include 1,2-dihydroxy-naph-
thalene dioxygenase, 2-hydroxychromene-2-carboxylate isomer-
ase, and 4-hydroxy-2-oxovalerate aldolase.
DISCUSSION
Failure in treating fungal infections with terbinafine has
been reported for patients infected with Trichophyton rubrum
(22) and C. albicans (32). In C. albicans, multidrug efflux trans-
porters have been implicated in resistance (35, 36). Thus, in
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standing of antifungal resistance mechanisms, mutants resis-
tant to terbinafine were isolated and characterized by classic
genetic analysis (30). We constructed a genomic library of one
such mutant, Terb7A, and through sib selection we identified
clone pD02 (Fig. 1), which encodes two previously unreported
genes: salA, which codes for a prokaryotic salicylate 1-mono-
oxygenase (2), and the C-terminal portion of the fasC gene,
which codes for the 	 subunit of the enzyme fatty acid syn-
thase.
Subcloning of pD02 and creation of plasmids carrying the
fasC (pD02/36fas)- or salA (pD02/36/sal)-encoding fragments
of pD02 (see Fig. 1C) revealed that only fragments containing
salA confer terbinafine resistance upon transformation into a
sensitive A. nidulans strain. Bacterial salicylate 1-monooxygen-
ase catalyzes the formation of catechol from salicylate, an
intermediate from naphthalene degradation (2). Thus, terbin-
afine, which has a naphthalene nucleus in its chemical struc-
ture (23–25, 39), could be the substrate for a similar degrada-
tion pathway in fungi, generating salicylate or an analogous
compound as substrate for the enzyme salicylate 1-monooxy-
genase in A. nidulans.
Most of the information about naphthalene metabolism has
been obtained from bacteria such as P. putida (41), with which
salicylate 1-monooxygenase is an extracellular flavoprotein
that catalyzes conversion of salicylate to catechol by introduc-
tion of a hydroxyl group with concomitant removal of a car-
boxyl group (16). In addition, naphthalene degradation is a
regulated process and involves nahR, a positive regulator of
transcription induced by salicylate (37).
In fungi, aromatic compounds are initially converted into
orthodiphenolic intermediates, e.g., catechol and protocat-
echuate, hydrolyzed between two hydroxyl groups and catab-
olized via the 	-ketoadipate pathway, producing succinate and
acetyl-coenzyme A (13).
Even though the genomic DNA library used in transforma-
tion experiments contained the tebA7 allele, which is geneti-
cally mapped to chromosome IV, we found one terbinafine-
resistance-conferring DNA fragment, which contains the salA
gene, physically mapped to chromosome VI. The physical lo-
cation of the salA DNA fragment was verified by three means:
(i) by DNA-DNA hybridization to pulsed-field-gel-electro-
phoresis-separated chromosomes, (ii) hybridization to a single
chromosome VI cosmid of the A. nidulans physical map (28),
and (iii) the determination that salA is on chromosome VI of
the fully sequenced genome A. nidulans database at the White-
head Institute (Cambridge, Mass.). Thus, we hypothesize that
an apparent multicopy effect of the salA gene observed by
Southern analysis of the pD02-salA transformant strains (Fig.
1B) may confer resistance to terbinafine in a manner similar to
the mutation in the tebA7 gene, supporting the suggestion of
Rocha et al. (30) that terbinafine resistance should involve
multiple genes that appear to act within a genetically regulated
circuit.
Northern blot experiments show (Fig. 2) increased salA tran-
script accumulation by terbinafine concentrations in wild-type
and Terb7, indicating that salA transcript accumulation is af-
fected by the presence of terbinafine and likely to be regulated
by tebA7. Furthermore, in pD02 transformants, salA is ex-
pressed at high levels, independent of the presence of terbin-
afine, suggesting that salicylate or an intermediary degradation
product is catalyzed more effectively in Terb7 and pD02 trans-
formant than in the wild type. Finally, when salA is less abun-
dant, levels of intracellular salicylate or an analogous com-
pound may be more elevated. In P. aeruginosa membrane
protein, synthesis associated with multiple drug resistance is
suppressed by the presence of salicylate in the cell, rendering
cells sensitive to different drugs (18).
The inalterable terbinafine sensitivity exhibited by the null
salA allele supports the idea that resistance is due to an altered
accumulation of salA transcript and the consequent increase in
salicylate 1-monooxygenase and degradation of the naphtha-
lene ring of terbinafine in the pD02 transformant compared to
the wild-type strain.
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